The University of Aberdeen’s reputation for ground-breaking fungal research has seen it afforded the prestigious status of an official UK centre of excellence.
The Medical Research Council (MRC) has awarded MRC Centre status for Medical Mycology to the University’s Aberdeen Fungal Group.
This new MRC Centre for Medical Mycology (MRC CMM) at the University of Aberdeen will spearhead innovative research and training to generate knowledge that will improve the diagnosis, prevention and treatment of fungal diseases.
This centre is the first MRC Centre dedicated to the field of medical mycology and is the first time that the University of Aberdeen has been awarded an MRC Centre status. There are only 22 MRC Centres in the UK.
The new MRC Centre for Medical Mycology represents a joint £6.5 million investment by both the MRC and the University of Aberdeen.
University of Aberdeen Principal and Vice-Chancellor, Professor Sir Ian Diamond, said, ‘The awarding of MRC Centre status to our already distinguished Aberdeen Fungal Group is testament to their world-leading research and learning they are already renowned for.
‘The university is investing in this new centre in partnership with the MRC because we are convinced that they will continue to make huge strides forward in this field to the benefit of science and society.’
